SCIENTIFIC PROGRAM
9.30 – 9:10 Opening
María Rodríguez, CUN. Ignacio Melero, CUN. Pamplona, Spain
9.10 -10.40 Chair:
Ignacio Melero, CUN. Pamplona, Spain
9.10 – 9.40 Immunological mechanisms of resistance to CDK4/6 inhibitors in breast cancer
Lorenzo Galluzzi. Weil Cornell. NYC, USA
9.40 – 10.10 Combining immunotherapy and radiotherapy
Maria Rodríguez Ruiz. CUN. Pamplona, Spain
10.10 – 10.40 Relevance of systemic inmunity to PDL1-PD1 blockade inmmunotherapy
David Escors. Navarrabiomed. Pamplona, Spain
10.40-11.00 Q & A
11.00 – 11.30 Coffee break
11.30 - 12.30 Chair:
María Rodríguez Ruiz, CUN. Pamplona, Spain
11.30 – 12.00 Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer
Fernando Lecanda. CIMA. Pamplona, Spain
12.00 – 12.30 Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Aitziber Buqué. Weil Cornell. NYC, USA
12.30 – 12-45 Q & A
12.45-13.45. How to get published in a high impact journal. Editor tips
Lorenzo Galluzzi. Weil Cornell. NYC, USA
13.45-14.00 Q & A
Event supported by
CRUK, FCAECC and AIRC under the C18915/A29362 Accelerator Award Program
INSCRIPCIONES en el email eguirado@unav.es
Event supported by
|
|
 |
|
 |
 |
